Victory: Gilead forced to withdraw Truvada® patent application in Argentina
Gilead prevented from obtaining an illegitimate monopoly at the expense of people’s health Activists in Argentina, including our partner...
#TreatPeopleRight – Highlights from the ITPC Annual Review
Campaign activity contributing to combined savings of US$700 million for health budgets is among ITPC’s 2016 highlights The mission of...
Infographic: How civil society action led to price reductions in Argentina
Civil society action means 27,000 more people could receive HIV treatment for 10 years. The price of 2 key HIV...
US-Argentina patent agreement presents public health concern
An alarming unbalanced three-year agreement could result in more unmerited patents in Argentina. As a global coalition of treatment activists...
Argentina: GEP filed new opposition to patent request for Hepatitis C drug
A significant step in ensuring access to treatment for the 800,000 people living with hepatitis C in Argentina. Earlier this...
Access to Medicines, Medical Technologies and Human Rights Meeting
15 years of the Doha Declaration on TRIPS and Public Health: The meeting will examine health safeguards as effective tools...
Seminar: Policies around Access to Medicines & Human Rights
Watch the presentations of the "Sustainability, Health Systems and Human Rights" at the Seminar on Policies of Access to Medicines and Human Rights.
Argentina civil society launch campaign “Big Pharma – Drop the case!”
Fundación Grupo Efecto Positivo (GEP), with regional partners, launches a campaign to demand that pharmaceutical companies drop their case which...
Right to Health at Regional Human Rights Hearing
Civil society groups request hearing about right to health and access to medicines at Inter-American Commission on Human Rights Fundación...
Defending Argentina’s public health from unmerited patents
Fundación Grupo Efecto Positivo defends Argentina’s public health from the abusive patents by multinational pharmaceutical companies Fundación Grupo Efecto Positivo...